Literature DB >> 15312769

Domain swapping in N-truncated human cystatin C.

Robert Janowski1, Magnus Abrahamson, Anders Grubb, Mariusz Jaskolski.   

Abstract

Human cystatin C (HCC) inhibits papain-like cysteine proteases by a binding epitope composed of two beta-hairpin loops and the N-terminal segment. HCC is found in all body fluids and is present at a particularly high level in the cerebrospinal fluid. Oligomerization of HCC leads to amyloid deposits in brain arteries at advanced age but this pathological process is greatly accelerated with a naturally occurring Leu68Gln variant, resulting in fatal amyloidosis in early adult life. When proteins are extracted from human cystatin C amyloid deposits, an N-terminally truncated cystatin C (THCC) is found, lacking the first ten amino acid residues of the native sequence. It has been shown that the cerebrospinal fluid may cause this N-terminal truncation, possibly because of disintegration of the leucocytes normally present in this fluid, and the release of leucocyte proteolytic enzymes. HCC is the first disease-causing amyloidogenic protein for which oligomerization via 3D domain swapping has been observed. The aggregates arise in the crystallization buffer and have the form of 2-fold symmetric dimers in which a long alpha-helix of one molecule, flanked by two adjacent beta-strands, has replaced an identical domain of the other molecule, and vice versa. Consistent with a conformational change at one of the beta-hairpin loops of the binding epitope, the dimers (and also any other oligomers, including amyloid aggregates) are inactive as papain inhibitors. Here, we report the structure of N-truncated HCC, the dominant form of cystatin C in amyloid deposits. Although the protein crystallized under conditions that are drastically different from those for the full-length protein, the structure reveals dimerization by the same act of domain swapping. However, the new crystal structure is composed of four independent HCC dimers, none of which has the exact 2-fold symmetry of the full-length dimer. While the four dimers have the same overall topology, the exact relation between the individual domains shows a variability that reflects the flexibility at the dimer-specific open interface, which in the case of 3D domain-swapped HCC consists of beta-interactions between the open hinge loops and results in an unusually long intermolecular beta-sheet. The dimers are engaged in further quaternary interactions resulting in spherical, closed octameric assemblies that are identical to that present in the crystal of the full-length protein. The octamers interact via hydrophobic patches formed on the surface of the domain-swapped dimers as well as by extending the dimer beta-sheet through intermolecular contacts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15312769     DOI: 10.1016/j.jmb.2004.06.013

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  22 in total

1.  Domain swapping and amyloid fibril conformation.

Authors:  Patrick C A van der Wel
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

2.  CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE.

Authors:  Jorge Ghiso; Yasushi Tomidokoro; Tamas Revesz; Blas Frangione; Agueda Rostagno
Journal:  Hirosaki Igaku       Date:  2010-07-08

3.  Open interface and large quaternary structure movements in 3D domain swapped proteins: insights from molecular dynamics simulations of the C-terminal swapped dimer of ribonuclease A.

Authors:  Antonello Merlino; Marc Antoine Ceruso; Luigi Vitagliano; Lelio Mazzarella
Journal:  Biophys J       Date:  2004-12-13       Impact factor: 4.033

4.  Prevention of amyloid fibril formation of amyloidogenic chicken cystatin by site-specific glycosylation in yeast.

Authors:  Jianwei He; Youtao Song; Nobuhiro Ueyama; Akira Saito; Hiroyuki Azakami; Akio Kato
Journal:  Protein Sci       Date:  2006-02       Impact factor: 6.725

5.  Sampling the N-terminal proteome of human blood.

Authors:  David Wildes; James A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-19       Impact factor: 11.205

6.  Amyloid-like fibrils from a domain-swapping protein feature a parallel, in-register conformation without native-like interactions.

Authors:  Jun Li; Cody L Hoop; Ravindra Kodali; V N Sivanandam; Patrick C A van der Wel
Journal:  J Biol Chem       Date:  2011-06-28       Impact factor: 5.157

7.  Crystallization and preliminary X-ray diffraction analysis of Val57 mutants of the amyloidogenic protein human cystatin C.

Authors:  Marta Orlikowska; Elzbieta Jankowska; Dominika Borek; Zbyszek Otwinowski; Piotr Skowron; Aneta Szymańska
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-11-26

Review 8.  Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.

Authors:  A Rostagno; J L Holton; T Lashley; T Revesz; Jorge Ghiso
Journal:  Cell Mol Life Sci       Date:  2009-11-07       Impact factor: 9.261

9.  Structural and functional analysis of the pro-domain of human cathelicidin, LL-37.

Authors:  Marzena Pazgier; Bryan Ericksen; Minhua Ling; Eric Toth; Jishu Shi; Xiangdong Li; Amy Galliher-Beckley; Liqiong Lan; Guozhang Zou; Changyou Zhan; Weirong Yuan; Edwin Pozharski; Wuyuan Lu
Journal:  Biochemistry       Date:  2013-02-21       Impact factor: 3.162

10.  Chemical chaperone and inhibitor discovery: potential treatments for protein conformational diseases.

Authors:  Jian-Hua Zhao; Hsuan-Liang Liu; Hsin-Yi Lin; Chih-Hung Huang; Hsu-Wei Fang; Shiao-Shing Chen; Yih Ho; Wei-Bor Tsai; Wen-Yih Chen
Journal:  Perspect Medicin Chem       Date:  2007-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.